Children's Oncology Group: Neuroectodermal Tumors, Primitive, Peripheral trials
The registry lists 10 Neuroectodermal Tumors, Primitive, Peripheral studies with Children's Oncology Group as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 2 4No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or LeukemiaCompletedNCT01154816Phase 2Results posted
- Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of TumorsCompletedNCT00618813Not applicableResults posted
- Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of TumorsCompletedNCT00070109Phase 2Results posted
- Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid TumorsWithdrawnNCT02011126Phase 2
- Genetic Biomarkers in Saliva Samples From Patients With Ewing SarcomaCompletedNCT01876303
- Collecting and Storing Biological Samples From Patients With Ewing SarcomaCompletedNCT00899990
- Study of Tumor Samples From Patients With Ewing SarcomaCompletedNCT00898053
- Evaluating Dactinomycin and Vincristine in Young Patients With CancerCompletedNCT00674193
- Diagnostic Study of Tumor Characteristics in Patients With Ewing's SarcomaCompletedNCT00048984
- Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00004078Phase 2